Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-13

Clinical Trial Update: FASST - Fetal Alcohol Spectrum Stimulant Trial [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for FASST, a study on fetal alcohol spectrum disorders sponsored by Monash Medical Centre.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Monash Medical Centre | Conditions: Fetal Alcohol Spectrum Disorders | Phase 4 | Status: UNKNOWN